Core Scientific, Inc.
CORZQ · OTC
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Revenue | $502,400 | $640,313 | $544,483 | $60,320 |
| % Growth | -21.5% | 17.6% | 802.7% | – |
| Cost of Goods Sold | $378,941 | $631,913 | $305,621 | $50,928 |
| Gross Profit | $123,459 | $8,400 | $238,862 | $9,392 |
| % Margin | 24.6% | 1.3% | 43.9% | 15.6% |
| R&D Expenses | $7,184 | $26,962 | $7,674 | $5,271 |
| G&A Expenses | $93,908 | $213,280 | $60,604 | $14,556 |
| SG&A Expenses | $100,927 | $226,011 | $64,666 | $16,327 |
| Sales & Mktg Exp. | $7,019 | $12,731 | $4,062 | $1,771 |
| Other Operating Expenses | $0 | $0 | $0 | -$110 |
| Operating Expenses | $108,111 | $252,973 | $72,340 | $21,598 |
| Operating Income | $8,961 | -$2,109,553 | $131,494 | -$6,327 |
| % Margin | 1.8% | -329.5% | 24.2% | -10.5% |
| Other Income/Exp. Net | -$261,152 | -$1,918,836 | -$103,565 | -$5,879 |
| Pre-Tax Income | -$245,804 | -$2,163,409 | $63,075 | -$12,206 |
| Tax Expense | $683 | -$17,091 | $15,763 | $0 |
| Net Income | -$246,487 | -$2,146,318 | $47,312 | -$12,206 |
| % Margin | -49.1% | -335.2% | 8.7% | -20.2% |
| EPS | -0.644 | -6.3 | 0.15 | -0.039 |
| % Growth | 89.8% | -4,300% | 489.6% | – |
| EPS Diluted | -0.644 | -6.3 | 0.15 | -0.039 |
| Weighted Avg Shares Out | 382,483 | 340,647 | 317,280 | 317,280 |
| Weighted Avg Shares Out Dil | 382,483 | 340,647 | 317,280 | 317,280 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $86,238 | $96,826 | $44,354 | $4,436 |
| Depreciation & Amortization | $96,445 | $226,093 | $33,362 | $9,403 |
| EBITDA | $114,323 | -$210,565 | $183,835 | $11,946 |
| % Margin | 22.8% | -32.9% | 33.8% | 19.8% |